QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)

Petros Pharmaceuticals (PTPI) SEC Filings & 10K Form

$0.67
-0.03 (-3.98%)
(As of 03:56 PM ET)

Recent Petros Pharmaceuticals SEC Filings

DateFilerForm TypeView
04/01/2024
3:31 PM
Petros Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/22/2024
3:31 PM
Petros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
2:38 PM
Ayrton Capital LLC (Filed by)
Petros Pharmaceuticals (Subject)
Form SC 13G
02/06/2024
9:23 AM
INTRACOASTAL CAPITAL, LLC (Filed by)
Petros Pharmaceuticals (Subject)
Form SC 13G/A
01/12/2024
3:32 PM
Petros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/28/2023
3:05 PM
Petros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/26/2023
4:05 PM
Bradley Greg (Reporting)
Petros Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2023
4:06 PM
Petros Pharmaceuticals (Issuer)
Silverman Joshua (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2023
4:06 PM
Arnold Mitchell (Reporting)
Petros Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2023
4:07 PM
Petros Pharmaceuticals (Issuer)
WALKER WAYNE REMELL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2023
4:07 PM
Boctor Fady (Reporting)
Petros Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2023
4:08 PM
Bernstein Bruce (Reporting)
Petros Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2023
4:11 PM
Petros Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/02/2023
7:00 AM
Petros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/19/2023
3:36 PM
Petros Pharmaceuticals (Filer)
Form 424B3
09/18/2023
11:15 PM
Petros Pharmaceuticals (Filer)
Form EFFECT
09/15/2023
4:16 PM
Petros Pharmaceuticals (Filer)
Form S-3/A
09/15/2023
3:22 PM
Petros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/25/2023
4:08 PM
Petros Pharmaceuticals (Filer)
Form DEF 14A
08/15/2023
4:03 PM
Petros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/21/2023
3:30 PM
Petros Pharmaceuticals (Filer)
Form D
Notice of Exempt Offering of Securities 
07/13/2023
3:41 PM
Petros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/28/2023
5:00 PM
Petros Pharmaceuticals (Issuer)
Silverman Joshua (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2023
5:01 PM
Petros Pharmaceuticals (Issuer)
WALKER WAYNE REMELL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2023
5:02 PM
Bernstein Bruce (Reporting)
Petros Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2023
5:03 PM
Bradley Greg (Reporting)
Petros Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:PTPI) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners